Prognostic prediction in liver cancer based on total tumor volume
Author Information
Author(s): Huo Teh I, Hsu Chia Y, Huang Yi H, Su Chien W, Lin Han C, Lee Rheun C, Chiou Yi Y, Chiang Jen H, Lee Pui C, Lee Shou D
Primary Institution: National Yang-Ming University School of Medicine, Taipei, Taiwan
Hypothesis
Can total tumor volume (TTV) serve as a reliable prognostic predictor for patients with hepatocellular carcinoma (HCC) undergoing locoregional therapy?
Conclusion
Total tumor volume is a feasible prognostic predictor for mortality risk in patients with hepatocellular carcinoma.
Supporting Evidence
- TTV was significantly larger in patients with higher serum α-fetoprotein levels.
- Patients with TTV 50-200 cm3 had a 74% increased mortality risk compared to those with TTV <10 cm3.
- Patients with TTV >500 cm3 had a 292% increased mortality risk compared to those with TTV <10 cm3.
- Child-Turcotte-Pugh score, performance status, vascular invasion, and TTV were significant independent prognostic predictors.
Takeaway
This study shows that the total size of tumors in the liver can help doctors predict how likely a patient is to survive cancer treatment.
Methodology
The study evaluated 786 patients undergoing locoregional therapy for HCC, assessing total tumor volume and its association with survival.
Limitations
The estimation of tumor volume assumes spherical tumors, which may not be accurate for irregularly shaped tumors.
Participant Demographics
Predominantly elderly (mean age 67 years), 73% male, with 50% having chronic HBV and 34% chronic HCV infections.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 0.78-1.65 for TTV 10-50 cm3; 95% CI: 1.15-2.64 for TTV 50-200 cm3; 95% CI: 1.24-3.72 for TTV 200-500 cm3; 95% CI: 2.55-6.03 for TTV >500 cm3
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website